A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLiĀ®) in Subjects With Post-stroke Upper Limb Spasticity


Phase 3 Results N/A

Summary of Purpose

This is a multicenter, double-blind, randomized, placebo-controlled study designed to compare Botulinum Toxin Type A for Injection (HengLiĀ®) with placebo on the efficacy and safety of treatment in post-stroke subjects with focal wrist, finger and in some cases, thumb spasticity. Approximately 180 subjects will be enrolled. The core period of the subjects will receive a single treatment session of intramuscular...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 September 2016.

1 Jul 2014 29 Oct 2014 1 Feb 2016 1 Sep 2016 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available